**Core Concept**
The management of pruritus in uremia involves addressing the underlying causes and symptoms. Pruritus, or itching, is a common complaint in patients with chronic kidney disease, particularly those on dialysis. Ultraviolet light therapy has been shown to be effective in alleviating pruritus in these patients.

**Why the Correct Answer is Right**
Ultraviolet light therapy works by stimulating the production of endorphins, which are natural pain-relieving chemicals in the body. This helps to reduce the sensation of itching. Additionally, ultraviolet light has anti-inflammatory properties, which can help to reduce the inflammation that contributes to pruritus. In patients with uremia, ultraviolet light therapy can also help to improve the quality of life by reducing the severity of itching.

**Why Each Wrong Option is Incorrect**
**Option B:** Cholestyramine is a bile acid sequestrant that can be used to treat pruritus in patients with primary biliary cirrhosis, but it is not effective in patients with uremia.
**Option C:** Eskazine is an antipsychotic medication that is not typically used to treat pruritus.
**Option D:** Topical benzocaine is a local anesthetic that can provide temporary relief from itching, but it does not address the underlying cause of pruritus in uremia.

**Clinical Pearl / High-Yield Fact**
Ultraviolet light therapy is a non-invasive and relatively low-cost treatment option for pruritus in uremia. It is often used in conjunction with other treatments, such as topical corticosteroids and antihistamines, to manage symptoms.

**✓ Correct Answer: A. Ultraviolet light**